Overall rank by patents
#2,974
of 49,997 tracked assignees
USPTO PatentsView assignee record - 128 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, New ranks #2,974 of 49,997 tracked US assignees by granted-patent volume, with 128 patents across 18 technology areas.
USPTO PatentsView assignee plate
Corpus R2974 · US Corporation #2,974 · 128 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Luminar Technologies, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Tianma Japan · near
48 score
Asahi Kasei Medical · near
48 score
Gachon University… · near
48 score
New England Biolabs · this assignee
48 score
Soonchunhyang… · near
48 score
3D Lighting… · lowest
7 score
What this shows New's Innovation Score is 48.2/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
New England Biolabs, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 78.9% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2015 (26 grants) versus a trough of 6 in 2017. By volume, New sits between Luminar Technologies, Inc. and TK Holdings, LLC.
From 2019–2021 to 2022–2024, New England Biolabs, Inc. moved from 33 to 35 grants (1.06x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,038. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Luminar Technologies, Inc.
128 patents
Microtech Knives, Inc.
128 patents
NCR Voyix Corporation
128 patents
Netease (HANGZHOU) Network Co., Ltd.
128 patents
Radio Systems Corporation
128 patents
Resonant Inc.
128 patents
Shanghai Bilibili Technology Co., Ltd.
128 patents
TK Holdings, LLC
128 patents
New England Biolabs, Inc.
128 patents
What this shows New holds 128 patents at rank #2,974, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,974 in granted patent volume.
Other assignees with the most granted patents in New's primary technology class.
Two PlainPatent-derived peer sets for New, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (48 here).
Nearest assignees by average claims per patent (15.5 here).
New's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 17% higher than 83% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 26 | 20.3% |
| 2016 | 9 | 7.0% |
| 2017 | 6 | 4.7% |
| 2018 | 16 | 12.5% |
| 2019 | 13 | 10.2% |
| 2020 | 8 | 6.3% |
| 2021 | 12 | 9.4% |
| 2022 | 16 | 12.5% |
| 2023 | 10 | 7.8% |
| 2024 | 9 | 7.0% |
| 2025partial year | 3 | 2.3% |
Top 15 of 18 technology areas
Overall rank by patents
#2,974
of 49,997 tracked assignees
48.2 out of 100
What to do with this data
New England Biolabs, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.